r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
A side-by-side editorial comparison of logrx and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.
A clinical-script logger that stopped shipping after its 0.2 line, changelogs made of merged PRs.
logrx produces execution logs for R scripts in regulated clinical work, recording what ran, what it returned, and which unapproved packages or functions were used. Its release notes are raw merged-PR lists rather than written changelogs, which makes the substance hard to read from the feed. The most recent release, 0.2.2 in June 2023, exists to track tidyselect and dplyr changes.
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
logrx produces execution logs for R scripts in regulated clinical work, recording what ran, what it returned, and which unapproved packages or functions were used. Its release notes are raw merged-PR lists rather than written changelogs, which makes the substance hard to read from the feed. The most recent release, 0.2.2 in June 2023, exists to track tidyselect and dplyr changes.
Feature work concentrated in the 0.1 line — return codes, a results writer, a to_report parameter, and logging of unapproved package and function use — and the 0.2 releases have been compatibility maintenance and hotfixes. Three years of silence in a pharmaverse that has otherwise kept shipping suggests the package reached the shape its users needed rather than that it was abandoned mid-design.
Nothing in these entries points to planned work; the likeliest trigger for a release is a breaking change in tidyverse dependencies, which is what produced the last one.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either logrx or pharmaverseadam.
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul took mocking back from webmockr and made it a property of the client itself
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
See all logrx alternatives → · See all pharmaverseadam alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
Both compete on the same themes — pharmaverse — within Analytics. logrx and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. logrx and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top logrx alternatives in Analytics are ranked by recent ship velocity. Browse the "logrx alternatives" section above for the current picks, or visit /alternatives/logrx for the full list with editorial commentary on each.
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.